Liabilities / Assets
26th percentile
Higher debt load relative to assets than 26% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.01x
Liabilities / Revenue
26th percentile
Higher debt load relative to revenue than 26% of similar nonprofits.
Net Margin
29th percentile
Higher net margin than 29% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
88th percentile
Faster asset growth than 88% of similar nonprofits.
Revenue Growth
56th percentile
Faster revenue growth than 56% of similar nonprofits.
Balance Sheet
Assets
Up$2,803,555
Up $682,423 (+32%) from 2012
Net Assets
Up$2,762,657
Up $671,603 (+32%) from 2012
Liabilities
Up$40,898
Up $10,820 (+36%) from 2012
Revenue And Expenses
Revenue
Up$1,875,303
Up $105,859 (+6.0%) from 2012
Expenses
Down$1,956,413
Down $32,110 (-1.6%) from 2012
Net Income
Up-$81,110
Up $137,969 (+63%) from 2012
Historical Trend
Filing Detail Status
This 2013 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2013 to Dec 31, 2013
Mission and Program Overview
Mission
Cure duchenne is a not-for-profit organization dedicated to coordinating and funding research necessary to find a cure for duchenne muscular dystrophy, increasing public awareness for duchenne muscular dystrophy, and improving their care and health.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2013 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $2,803,555
- Liabilities
- $40,898
- Net assets
- $2,762,657
- Revenue
- $1,875,303
- Expenses
- $1,956,413
- Net income
- -$81,110